A Multicenter, RAndomlzed, coNtrolled, umBrella Trial fOr Minimally Invasive Neurosurgery With Al-assisted Robotic guidanCe for Hemorrhagic Stroke: Large Basal Ganglia Hemorrhage

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

About this trial

This substudy is a prospective, multicenter, parallel-controlled, randomized controlled trial designed to evaluate whether robot-assisted endoscopic evacuation of large basal ganglia hematomas can improve patient outcomes compared with traditional surgical approaches such as small craniotomy or large-bone-flap intracranial hematoma evacuation.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age ≥18 years at randomization;

Diagnosed with hypertensive basal ganglia hemorrhage via imaging (CT, CTA, etc.);

Hematoma volume ≥30 mL prior to randomization;

Glasgow Coma Scale (GCS) score ≥ 5;

Disqualifiers

Hematoma involving the thalamus (volume >5 mL or diameter >2 cm), midbrain, or ventricles (Graeb score ≥3), or other locations;

Radiologically confirmed cerebral vascular abnormalities including ruptured aneurysms, arteriovenous malformations (AVMs), or Moyamoya disease; hemorrhagic transformation of ischemic infarcts; or recent (within 1 year) recurrence of intracerebral hemorrhage;

Signs of impending herniation such as midline shift exceeding 1 cm or ipsilateral pupillary changes;

Any irreversible coagulation disorder or known coagulopathy; platelet count <100,000; INR >1.4; or use of anticoagulant medication within 7 days before the current hemorrhage;

Trial design

Design model

Parallel

Treatments tested in this trial

  • Robot-Assisted Endoscopic Minimally Invasive Surgery

    Procedure/Surgery

    Neurosurgeons participating in the robot-assisted endoscopic procedure must be qualified doctors who have completed standardized training and certification by the coordinating center. They must be capable of performing endoscopic hematoma evacuation and managing common intraoperative complications. Each certified surgeon is required to regularly review the surgical protocol and the technical components of the procedure. Surgical trajectory: The incision and burr-hole location are determined using an AI-integrated neuroimaging automatic surgical trajectory planning system. The planning principles include, but are not limited to: avoiding critical functional areas such as language and motor cortices; avoiding vascular-dense regions; and selecting the individualized optimal trajectory based on the three-dimensional morphology and spatial orientation of the hematoma. Plan review by supporting units: All preoperative imaging data and trajectory plans are automatically stored and uploaded b

  • Traditional Surgical Approaches

    Procedure/Surgery

    A small craniotomy or large bone flap craniotomy is performed to microscopically evacuate the basal ganglia hematoma, followed by electrocoagulation for hemostasis. Depending on preoperative brain herniation or intraoperative brain swelling, the surgeon may decide whether to remove the bone flap.

Treatment groups

198 Participants
are divided into 2 treatment groups
Group A: Robot-Assisted Endoscopic Minimally Invasive SurgeryExperimental treatment 1 intervention
Group B: Traditional Surgical ApproachesSham comparator 1 intervention

Trial outcomes

Primary outcomes

1

Modified Rankin Scale (mRS) score at 6 months

The primary analysis will compare differences between the two groups based on utility-weighted mRS.

Time frame
up to 6 months

Secondary outcomes

1

Ordinal shift in mRS scores at 6 months (ordinal shift)

The difference in the distribution of scores on the modified Rankin Scale (mRS, range 0-6) between the treatment and control groups was assessed at 6 months after onset (or treatment) using a shift analysis.

Time frame
up to 6 months
2

Favorable functional outcome at 6 months (mRS 0-1)

The proportion of patients achieving an excellent functional outcome (defined as mRS score of 0 or 1) at 6 months.

Time frame
up to 6 months
3

Functional independence at 6 months (mRS 0-2)

The proportion of patients achieving functional independence (defined as mRS score of 0, 1, 2) at 6 months.

Time frame
up to 6 months
4

Health-related quality of life (HRQoL) at 6 months, assessed by the EQ-5D-5L questionnaire

Assessed using the EQ-5D-5L questionnaire at 6 months post-onset/post-surgery. The instrument comprises five dimensions (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression) with five levels of severity, plus a Visual Analogue Scale (EQ-VAS)

Time frame
up to 6 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Lead sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Collaborator

Affiliated Hospital of Nantong University

Collaborator

The First People's Hospital of Lianyungang

Collaborator

Huashan Hospital

Collaborator

China-Japan Friendship Hospital

Collaborator

The First Affiliated Hospital of Zhengzhou University

Collaborator

Second Affiliated Hospital of Xi'an Jiaotong University

Collaborator

Shaoxing Central Hospital

Collaborator

Jinhua Central Hospital

Collaborator

The Second Affiliated Hospital of Kunming Medical University

Collaborator

First Affiliated Hospital of Guangxi Medical University

Collaborator

First Affiliated Hospital of Chongqing Medical University

Collaborator

Shanghai East Hospital

Collaborator

The First Affiliated Hospital of Anhui Medical University

Collaborator

Renmin Hospital of Wuhan University

Collaborator

The First Affiliated Hospital of Nanchang University

Collaborator

Aerospace Center Hospital

Collaborator

Hebei General Hospital

Collaborator

First Affiliated Hospital of Harbin Medical University

Collaborator

The Affiliated Hospital of Inner Mongolia Medical University

Collaborator

Jinshan Hospital Fudan University

Collaborator

Minhang District Central Hospital of Shanghai

Collaborator